HIPOPIGMENTĂRI CUTANATE

DOI: 10.7241/ourd.2022book.2_16

First Page (Prima pagina)

 

HIPOPIGMENTĂRI CONGENITALE
I. Leziune hipopigmentară mica unică
1. Hamartom (nev) acromic
2. Hamartom anemic
II. Leziune hipopigmentară de dimensiuni mari
III. Leziuni hipopigmentare multiple de dimensiuni mici: scleroza tuberoasă Bourneville
IV. Lezuini hipoigmentarede forme diferite
A. Hipopigmentări de-a lungul liniilor Blaschko: mozaicism cutanat ?i hipomelamoza Ito
B. Hipopigmentare de tip vitiligo ?i depigmentarea părului în regiunea frontală (me?ă albă):
? Piebaldism
? Sindrom Waardenburg
V. Hipopigmentare generalizată
A. Albinism
B. Sindrom Hermansky-Pudlak (SHP)
C. Sindrom Chediak-Higashi (SCH)
D. Sindrom Griscelli-Prunieras (SGP)
E. Hipomelamoza din bolile metabolice
? Fenilcetonurie
? Homocistinurie
? Boala Menkes

HIPOPIGMENTĂRI DOBÂNDITE
I. Vitiligo
II. Alte Hipopigmentări
A. Pitiriazis alb
B. Dermatită atopică
C. Lichen striat
D. Parapsoriazis în picătură
E. Micozis fungoides
F. Hipopigmentări post-inflamatorii
G. Nev cu halou (nev Sutton)
H. Lichen sclera-atrofic vulvar
I. Pitiriazis versicolor
J. Lepră
K. Hipopigmentări chimice
L. Sindrom Vogt-Koyanagi Harada

Keywords

  • Hipomelanoza; melanocitopenic; melaninopenic; HAMARTOM (NEV) ACROMIC; HAMARTOM ANEMIC; LEZIUNI HIPOPIGMENTARE MICI MULTIPLE; Hipopigmentarea ?în confeti; Placa fibroasă pigmentară; Plăcile tip ?peau de chagrin?; Angiofibroamele faciale; Angiofibroamele unghiale; HIPOMELANOZĂ ITO; PIEBALDISM; SINDROM WAARDENBURG; ALBINISM; SINDROMUL HERMANSKY-PUDLAK; SINDROMUL CHEDIAK-HIGASHI; SINDROMUL GRISCELLI-PRUNIERAS; FENILCETONURIE; HOMOCISTINURIE; BOALA MENKES; VITILIGO; Fototerapie; Laserterapie; PITIRIAZIS ALB; DERMATITĂ ATOPICĂ; DERMATITĂ SEBOREICĂ; HIPOMELANOZA ERUPTIVĂ; LICHEN STRIAT; HIPOPIGMENTĂRI POST-INFLAMATORII; NEV cu HALOU; PITIRIAZIS VERSICOLOR ALBA; DEPIGMENTĂRI IATROGENE; SINDROM VOGT-KOYANAGI HARADA

References

1. Lee HS, Chun YS, Hann SK. Nevus depigmentosus: Clinical features and histopathologic characteristics in 67 patients. J Am Acad Dermatol. 1999;40:21-6.
2. Katugampola GA, Lanigan SW. The clinical spectrum of naevus anaemicus and its association with port wine stains: report of 15 cases and a review of the literature. Br J Dermatol. 1996;134:292-5.
3. Marque M, Roubertie A, Jaussent A, et al. Nevus anemicus in neurofibromatosis type 1: A potential new diagnostic criterion. J Am Acad Dermatol. 2013;69:768-75.
4. Di Lernia V. Segmental nevus depigmentosus: analysis of 20 patients. Ped Dermatol. 1999;16:349-53.
5. Randle SC. Tuberous Sclerosis Complex: A Review. Pediatr Ann. 2017;46:e166-e171.
6. Webb DW, Clarke A, Fryer A, et al. The cutaneous features of tuberous sclerosis: a population study. Br J Dermatol. 1996;135:1-5.
7. Crino PB, Nathanson KL, Henske EP. The tuberous sclerosis complex. N Engl J Med. 2006;355:1345-56.
8. Curatolo P, Bombardieri R, Jozwiak S. Tuberous sclerosis. Lancet. 2008;372:657-68.
9. Wataya-Kaneda M, Tanaka M, Yang L, et al. Clinical and Histologic Analysis of the Efficacy of Topical Rapamycin Therapy Against Hypomelanotic Macules in Tuberous Sclerosis Complex. JAMA Dermatol. 2015;151:722-30.
10. Bolognia JL, Orlow SJ, Glick SA. Lines of Blaschko. J Am Acad Dermatol. 1994;31:157-90.
11. Happle R. Mosaicism in human skin. Arch Dermatol. 1993;129:1460-70.
12. Taibjee SM, Bennett DC, Moss C. Abnormal pigmentation in hypomelanosis of Ito and pigmentary mosaicism: the role of pigmentary genes. Br J Dermatol. 2004;151:269-82.
13. Sybert VP. Hypomelanosis of Ito: a description, not a diagnosis. J Invest Dermatol. 1994;103:141S-3S.
14. Dessinioti C, Stratigos AJ, Rigopoulos D, et al. A review of genetic disorders of hypopigmentation: lessons learned from the biology of melanocytes. Exp Dermatol. 2009;18:741-9.
15. El Amraoui M, Khalidi M, Frikh R, et al. A Moroccan case of piebaldism in an infant as part of a family phenotype. Our Dermatol Online. 2020;11:e178.1-e178.2.
16. Pingault V, Ente D, Dastot-Le Moal F, et al. Review and update of mutations causing Waardenburg syndrome. Hum Mutat. 2010;31:391-406.
17. Oetting WS, King RA. Molecular basis of albinism: mutations and polymorphisms of pigmentation genes associated with albinism. Hum Mutat. 1999;13:99-115.

18. Rooryck C, Morice F, Mortemousque B, et al. Albinisme oculo-cutane? . Ann Dermatol Venereol. 2007;134C2:55-64.
19. Wei ML. Hermansky-Pudlak syndrome: a disease of protein trafficking and organelle function. Pigment Cell Res. 2006;19:19-42.
20. Certain S, Barrat F, Pastural E, et al. Protein truncation test of LYST reveals heterogenous mutations in patients with Chediak-Higashi syndrome. Blood. 2000;95:979-83.
21. Ménasché G, Pastural E, Feldmann J, et al. Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome. Nat Genet. 2000;25:173-6.
22. Ortonne JP, Mosher DB, Fitzpatrick TB. Vitiligo and others hypomelanoses of hair and skin. New York: Plenum ed. 1983;683 p.
23. Ammour A, Jouary T, Tai?eb A, Mazereeuw-Hautier J; Socie? te? franc? aise de dermatologie pe? diatrique. Le vitiligo de l?enfant Ann Dermatol Venereol. 2010;137:654-8.
24. Mazereeuw-Hautier J, Bezio S, Mahe E, et al; Groupe de Recherche Clinique en Dermatologie Pe? diatrique (GRCDP). Segmental and nonsegmental childhood vitiligo has distinct clinical characteristics: a prospective observational study. J Am Acad Dermatol. 2010;62:945-9.
25. Krüger C, Smythe JW, Spencer JD, et al. Significant immediate and long-term improvement in quality of life and disease coping in patients with vitiligo after group climatotherapy at the Dead Sea. Acta Derm Venereol. 2011;91:152-9.
26. McCoy J, Goren A, Lotti T. In vitro evaluation of a novel topical cream for vitiligo and psoriasis that selectively delivers NB-UVB therapy when exposed to sunlight. Dermatol Ther. 2014;27:117-20.
27. Gianfaldoni S, Zanardelli M, Lotti. Vitiligo repigmentation: what?s new? J Dermatolog Clin Res. 2014;2:1023.
28. Lotti TM, Hercogova J, D?Erme AM, et Al. UVA -1 Light vs UVA -1 Laser emission Devices. In UVA1 in dermatology. Evidence, data, hypotheses. Nuova Prhomos Publishing House Italy. 2013:68-71.
29. Korobko IV, Lomonosov KM. Acridone acetic acid, sodium salt, as an agent to stop vitiligo progression: a pilot study. Dermatol Ther. 2014;27:219-22.
30. Ramaiah A, Kar HK, Garg VK, et al. A Double Blind Randomized Phase IV Clinical Trial of basic Fibroblast Growth Factor Related Decapeptide in Vitiligo. Pigmentary Disorders S. 2015;3:S3-004.
31. Prignano F, Pescitelli L, Becatti M, et al. Ultrastructural and functional alterations of mitochondria in perilesional vitiligo skin. J Dermatol Sci. 2009;54:157?67.
32. Lotti T, Hercogova J, Wollina U, et al. Treating skin diseases according to the low dose medicine principles. Data and hypotheses. J Biol Regul Homeost Agents. 2015;29(1 Suppl):47- 51.
33. Cuny JF, Truchetet F. Lichen striatus. Ann Dermatol Venereol. 2001;128:275-9.
34. Taieb A, El Youbi A, Grosshans E, et al. Lichen striatus: a Blaschko linear acquired inflammatory skin eruption. J Am Acad Dermatol. 1991;25:637-42.
35. Zawar V, Bharatia P, Chuh A. Eruptive hypomelanosis: a novel exanthem associated
with viral symptoms in children. JAMA Dermatol. 2014;150:1197-201.

Comments are closed.